Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Innovus Pharma’s Apeaz™ Drug for Arthritis Pain Relief Approved for Commercialization in Canada as a Natural Health Product

Wednesday, January 31, 2018

Innovus Pharmaceuticals Inc an emerging commercialstage pharmaceutical company that delivers safe innovative and effective overthecounter medicine and consumer care products to improve mens and womens health and respiratory diseases today announced t...

Puma Biotechnology and Medison Pharma Enter into Exclusive Licensing Agreement to Commercialize NERLYNX® (neratinib) in Israel

Wednesday, January 31, 2018

Puma Biotechnology Inc a biopharmaceutical company and Medison Pharma Ltd Israels leading commercial partner for innovative pharmaceuticals have entered into an exclusive agreement under which Medison will commercialize NERLYNX neratinib in Israel...

WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing Collaboration Following Successful IND Filing for AVB-S6-500

Tuesday, January 30, 2018

WuXi Biologics a leading global openaccess biologics technology platform company offering endtoend solutions for biologics discovery development and manufacturing and Aravive Biologics Inc today announced plans to expand their biologics manufacturing...

Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin (TD-4208) in Adults with Chronic Obstructive Pulmonary Disease

Tuesday, January 30, 2018

Theravance Biopharma Inc and Mylan NV today announced that the US Food and Drug Administration FDA has accepted for review the companies recently submitted New Drug Application NDA for revefenacin TD an investigational longacting muscarinic antagonis...

ZZ Biotech Announces Preliminary Phase 2 Stroke Trial Results with 3K3A-APC

Monday, January 29, 2018

ZZ Biotech today announced that preliminary results of RHAPSODY the companys Phase clinical trial in acute ischemic stroke patients were presented at the International Stroke Conference in Los AngelesThe placebocontrolled doseescalation trial w...

Preliminary Data from FIREFISH trial in Type 1 SMA Infants Presented at the International Scientific Congress on Spinal Muscular Atrophy

Monday, January 29, 2018

PTC Therapeutics Inc announced the presentation of early interim data from Part the dosefinding portion of the FIREFISH study FIREFISH is a twopart seamless openlabel multicenter study to investigate the safety and efficacy of RG in infants and babi...

Araclon Biotech Partners with TFS International for Their Alzheimer’s Phase II Trial

Monday, January 29, 2018

After completing a successful phase I partnership with TFS International TFS Araclon Biotech a Grifols company decided to continue the partnership with TFS advancing their Alzheimers disease AD vaccine ABvac into phase II The placebocontrolled phase...

Medical Manufacturing Asia 2018: Delivering solutions for the future of Medtech

Friday, January 12, 2018

Innovative medical technology is an increasingly important driver for delivering efficiencies in the global healthcare system Through advances in medical technology precision engineering micromanufacturing processes and IT medical devices and solutio...

Clover Biopharmaceuticals selects GE’s FlexFactory biomanufacturing platform for its new production facility in China

Thursday, January 25, 2018

Clover Biopharmaceuticals a biotechnology company focused on developing novel and transformative biologic therapies has chosen GE Healthcares FlexFactory a biomanufacturing platform based on singleuse technologies for its new facility located in Chan...

FDA Grants Approval to Shire for Technology Transfer of CINRYZE® Drug Product Manufacturing Process to Vienna, Austria Manufacturing Site

Thursday, January 25, 2018

Shire plc the global biotechnology leader in rare diseases announced today that the US Food and Drug Administration has granted approval for the technology transfer of CINRYZE C esterase inhibitor human drug product manufacturing process to its Vienn...